Program 6 Month Injectable For Cats

Program 6 Month Injectable For Cats

Program 6 Month Injectable For Cats Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Do not use in dogs. A severe local reaction may occur in dogs that is not seen in cats.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

PROGRAM 6 Month Injectable for Cats is indicated for use in cats, six weeks of age and older, for the control of flea populations.

Lufenuron controls flea populations by preventing the development of flea eggs and does not kill adult fleas. Concurrent use of insecticides may be necessary for adequate control of adult fleas.

History

There is currently no drug history available for this drug.

Other Information

PROGRAM® (lufenuron) 6 Month Injectable for Cats is available in two syringe sizes for subcutaneous administration to cats and kittens according to their weight (See Dosage). Each preloaded syringe is formulated to provide 4.54 mg/pound (10 mg/kg) body weight of lufenuron. The active ingredient of PROGRAM 6 Month Injectable for Cats is lufenuron, a benzoylphenyl-urea derivative with the following chemical composition: N-[2,5-dichloro-4-(1,1,2,3,3,3,-hexafluoropropoxy)-phenylaminocarbonyl]-2,6-difluorobenzamide. Benzoylphenyl-urea compounds, including lufenuron, are classified as insect development inhibitors (IDIs).

Program 6 Month Injectable For Cats Manufacturers


  • Novartis Animal Health Us, Inc.
    Program 6 Month Injectable For Cats (Lufenuron) Injection, Suspension [Novartis Animal Health Us, Inc.]

Login To Your Free Account